TYLOR ROCKWELL: Open Payments
NPI 1336909100 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 45 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $332 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $207 |
| Lundbeck LLC | 8 | $145 |
| Axsome Therapeutics, Inc. | 6 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Orexo US, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Braeburn Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, Auvelity, CAPLYTA, Zubsolv, TRINTELLIX, INGREZZA, BRIXADI.
Industry payments across WI — which companies pay providers there.
